Effect of amantadine on sexual dysfunction in neuroleptic-treated male schizophrenic patients

Clinical Neuropharmacology

Volumn 21, Issue 6, 1998, Pages 355-357

  Valevski, Avi ^a,b   Modai, Ilan ^c   Zbarski, Elena ^c   Zemishlany, Zvi ^a,b   Weizman, Abraham ^a,b  

^a GEHA MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHA'AR MENASHE MENTAL HEALTH CENTER   (Israel)

Author keywords

Amantadine; Neuroleptics; Schizophrenia; Sexual dysfunction

Indexed keywords

AMANTADINE; FLUPHENAZINE DECANOATE; HALOPERIDOL DECANOATE; NEUROLEPTIC AGENT; PERPHENAZINE; PROLACTIN; THIORIDAZINE;

ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; HUMAN; MALE; PENIS ERECTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SATISFACTION; SCHIZOPHRENIA; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION;

ADULT; AMANTADINE; ANTIPSYCHOTIC AGENTS; DOPAMINE AGENTS; HUMANS; MALE; SCHIZOPHRENIA; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 0031754668     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Barnes TR, Bamber RW, Watson JP. Psychotropic drugs and sexual behavior. Br J Hosp Med 1979;21:594-600.
2. Weiss HD. The physiology of human penile erection. Ann Intern Med 1972;76:793-9.
3. Melis MR, Argiolas A. Dopamine and sexual behavior. Neurosci Biobehav Rev 1995;19:19-38.
4. Pfaus JG, Phillips AG. Differential effects of dopamine receptor antagonists on the sexual behavior of male rats. Psychopharmacology (Berlin) 1989;98:363-8.
5. Segraves RT. Effects of psychotropic drugs on human erection and ejaculation. Arch Gen Psychiatry 1989;46:275-84.
6. Ferraz MR, Santos R. Amantadine stimulates sexual behavior in male rats. Pharmacol Biochem Behav 1995;51:709-14.
7. Balogh S, Hendricks SE, Kang J. Treatment of fluoxetine-induced anorgasmia with amantadine. J Clin Psychiatry 1992;53:212-3.
8. Correa N, Opler LA, Kay SR, Birmaher B. Amantadine in the treatment of neuroendocrine side effects of neuroleptics. J Clin Psychopharmacol 1987;7:91-5.
9. American Psychiatric Association. DSM-IV: Diagnostic Statistical Manual of Mental Disorders, 4th ed. Washington, DC: The American Psychiatric Association, 1994.
10. Aizenberg D, Gur S, Zemishlany Z, Granek M, Jeczmien P, Weizman A. Mianserin, a 5-HT 2a/c and α2 antagonist in the treatment of sexual dysfunction induced by serotonin reuptake inhibitors. Clin Neuropsychopharmacol 1997;30:210-4.
11. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophren Bull 1987; 13:261-76.
12. Silver H, Geraisy N. No difference in the effect of biperiden and amantadine on negative symptoms in medicated chronic schizophrenic patients. Biol Psychiatry 1995;38:413-5.
13. Uitti RJ, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B. Hypersexuality with antiparkisonian therapy. Clin Neuropharmacol 1989;12:375-83.